Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,908,928
+$1,793,718 QoQ
Shares Held
78,176
+122.4% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 252 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Dec 31, 2024CallValue
$1,741,103
CallShares
68,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. CLDX ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CLDX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,908,928 | 78,176 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,115,210 | 35,158 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,487,828 | 91,599 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,752,847 | 67,756 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $880,665 | 43,276 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $605,809 | 33,378 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $821,223 | 32,498 | Shares | Defined | 2025-02-13 | |
| 2024-12-31 | $1,741,103 | 68,900 | Call | Defined | 2025-02-13 | |
| 2024-09-30 | $761,748 | 22,411 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $841,458 | 22,736 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $907,179 | 21,615 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $585,142 | 14,754 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,151,132 | 41,829 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,835,644 | 54,101 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,208,386 | 33,585 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $46,664 | 1,047 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $72,072 | 2,564 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $75,702 | 2,808 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,118,221 | 32,831 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,804,950 | 46,712 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,089,785 | 20,185 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,982 | 149 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,480 | 169 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $867,185 | 49,497 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $5,664 | 382 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,263 | 251 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $547 | 330 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||